Channels - Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease :: FRELIP Discovery

Similar Items: Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Quick Look
Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)
Quick Look
Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Quick Look
Metabolic Dysfunction–Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations
Quick Look
The Economic Burden of Metabolic Dysfunction‐Associated Steatohepatitis (MASH) With Cirrhosis: A Systematic Review
Quick Look
NADPH Oxidases in Chronic Liver Diseases
Quick Look
Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
Quick Look
Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
Quick Look
Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease
Quick Look
Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver Disease
Quick Look
A comparison of plasma Tsukushi in adolescents with and without metabolic dysfunction‐associated steatotic liver disease
Quick Look
Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications
Quick Look
Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021
Quick Look
Correction to “Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021”
Quick Look
Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1
Quick Look
Noninvasive Biomarkers of Liver Fibrosis: An Overview
Quick Look
Correction to “Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1”
Quick Look
Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease
Quick Look
Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in the intensive care unit admitted from the emergency department: A single-center, historical cohort study
Quick Look
Commentary: White matter functional connectome gradient dysfunction in major depressive disorder
Quick Look
Correction: Endovascular therapy for erectile dysfunction: insights from more than 1000 treatments
Quick Look
Left Ventricular Diastolic Dysfunction Increases the Risk of Medium-term Mortality in Patients with Cirrhotic Ascites
Quick Look
When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
Quick Look
Newly Identified Mechanisms of Total Parenteral Nutrition Related Liver Injury
Quick Look
Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction‐Associated Steatotic Liver Disease